Changes in clinical, biochemical, immunological and integrative parameters in patients with chronic hepatitis C virus infection according to the virus genotype and the grade of activity

The aim of this study is to determine the features of the course of chronic hepatitis C virus (CHCV) infection and the dependence of changes in integrative indicators of endogenous intoxication, nonspecific immunoreactivity and inflammation on the virus genotype and the grade of activity. Materia...

Full description

Bibliographic Details
Main Authors: A. H. Lishnevska, M. D. Chemych
Format: Article
Language:English
Published: Zaporozhye State Medical University 2020-08-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/208363/211686
id doaj-cb07784f5eeb47bc8c24742f86d38800
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author A. H. Lishnevska
M. D. Chemych
spellingShingle A. H. Lishnevska
M. D. Chemych
Changes in clinical, biochemical, immunological and integrative parameters in patients with chronic hepatitis C virus infection according to the virus genotype and the grade of activity
Zaporožskij Medicinskij Žurnal
chronic hepatitis c virus
genotype
activity
clinical and biochemical blood test
integrative parameters
author_facet A. H. Lishnevska
M. D. Chemych
author_sort A. H. Lishnevska
title Changes in clinical, biochemical, immunological and integrative parameters in patients with chronic hepatitis C virus infection according to the virus genotype and the grade of activity
title_short Changes in clinical, biochemical, immunological and integrative parameters in patients with chronic hepatitis C virus infection according to the virus genotype and the grade of activity
title_full Changes in clinical, biochemical, immunological and integrative parameters in patients with chronic hepatitis C virus infection according to the virus genotype and the grade of activity
title_fullStr Changes in clinical, biochemical, immunological and integrative parameters in patients with chronic hepatitis C virus infection according to the virus genotype and the grade of activity
title_full_unstemmed Changes in clinical, biochemical, immunological and integrative parameters in patients with chronic hepatitis C virus infection according to the virus genotype and the grade of activity
title_sort changes in clinical, biochemical, immunological and integrative parameters in patients with chronic hepatitis c virus infection according to the virus genotype and the grade of activity
publisher Zaporozhye State Medical University
series Zaporožskij Medicinskij Žurnal
issn 2306-4145
2310-1210
publishDate 2020-08-01
description The aim of this study is to determine the features of the course of chronic hepatitis C virus (CHCV) infection and the dependence of changes in integrative indicators of endogenous intoxication, nonspecific immunoreactivity and inflammation on the virus genotype and the grade of activity. Materials and methods. In total, 287 CHCV patients were examined and their inpatient and outpatient medical cards were analyzed. The study included 55 healthy individuals. In addition to the general group, which included all the patients, the examined people were divided into groups, depending on the grade of activity (minimal activity – 210 people, moderate – 68, expressed – 9) and the virus genotype (1b – 150 people, 2 – 19, 3a – 102). Clinical and laboratory examination was performed according to the protocol. The integrative indices of severity, nonspecific reactivity, indices of inflammation and intoxication activity were also calculated. The statistical processing of the obtained results was carried out by Microsoft Office Excel 2010 and IBM SPSS Statistic 23 computer software. Results. The groups were sex- and age-representative. The 1b genotype (52.30 %), moderate liver fibrosis (F2 – 31.25 %) and minimal activity (73.17 %) were the most frequently encountered in patients with CHCV. The most frequent clinical manifestations were asthenovegetative syndrome (81.88 %) and heaviness in the right hypochondrium (64.76 %). Patients with CHCV caused by different virus genotypes had evenly distributed clinical data (P > 0.05), with the exception of the 1b genotype patients who were diagnosed with telangiectasia 1.3 times more frequently than in the total sample; and liver enlargement were 1.5 times (P < 0.05) less frequently seen in the 2 genotype patients, there were no anemia cases (P < 0.05). A decrease in platelet counts (1.3 times) and segmented neutrophils (1.2 times) as well as an increase in lymphocytes (1.1 times) and ESR (1.4 times) was observed in CHCV patients compared to apparently healthy individuals (P < 0.05). The changes obtained were significant in the groups with all genotypes, except for the patients with genotype 2 as the level of erythrocytes and hemoglobin was lower than in the comparison group and in the total group (1.1 times in all cases, P < 0.05), and patients with genotype 3 had a lower ESR compared to all patients (1.2 times) (P < 0.05). The groups of patients with different grades of activity were homogeneous with the exception that the leukocyte count in minimal activity (P < 0.05) was lower than in the total group, ESR was higher only in the total group in minimal activity (P < 0.05), the level of segmented neutrophils and lymphocytes in expressed activity did not differ from the comparison group, unlike other groups. In the total group, leukopenia (15.68 %), erythrocytopenia (18.47 %), anemia (6.62 %), and thrombocytopenia (33.10 %) were more common than in the comparison group (5.45 %, 3.63%, 0 %, 5.45 %, respectively) (P < 0.05). People with different HCV genotypes had similar changes, except for the patients with genotype 2 who did not have anemia. All CHCV patients had higher values of total protein, ALT, AST, GGT relative to the comparison group (P < 0.05), and AlP and creatinine were lower (P < 0.05). No dependence of changes in these parameters on the genotype was found, except for protein content, as it was higher in the groups with genotype 1c and 2; AlP was lower in individuals with the 1c and 3a, and creatinine – in 1c and 2 genotype patients (P < 0.05). There was also no dependence of changes in patients with CHCV on the grade of activity, except for those with expressed activity who had higher AlP, GGT and total bilirubin with reduced glucose level (P < 0.05). In the total group of patients with CHCV, the entropy indices of leukocyte formula were higher, the indexes of nonspecific reactivity had higher values of RC (1.3 times), Ilimph (1.3 times), IA (1.1 times), but NMRI (1.1 times) and ELRI (1.3) (P < 0.05) were lower than in the comparison group. There was a decrease (TII – 1.1 times; KI– 1.3 times) or an increase (ILG – 1.3 times; IL ESR – 1.5 times) in inflammatory parameters (P < 0.05). Indices of endogenous intoxication were decreased in patients compared with the healthy individuals (ILS – 1.2 times, NRR – 1.8 times). No dependence of changes in patients with CHCV on the genotype was found, except for IA, which was higher only in the total group and with genotype 3a (P < 0.05), and IL ESR in the patients with genotype 3a, which was lower than in the total group (P < 0.05) but did not differ from the comparison group (p> 0.05); IIS with genotype 3a was 1.7 times lower compared with all patients (P < 0.05). The ELR indicator did not change in all grades of activity and did not differ from those of healthy individuals. In patients with moderate activity, IA was higher than in the comparison group and NI was lower than in the total group (P < 0.05). Abdominal ultrasound, regardless of the group, most frequently revealed liver enlargement (76.26% of persons) and an increase in its echogenicity (82.35 %). Conclusions. Chronic hepatitis C virus patients were dominated by asthenovegetative syndrome, feeling of heaviness in the right hypochondrium, liver enlargement, increase in lymphocyte count, ESR, transaminase activity. Telangiectasia in genotype 1b and liver enlargement in genotype 2 were less frequent. Laboratory changes were accompanied by leukocytopenia, erythrocytopenia, anemia and thrombocytopenia, an increase in total protein content, ALT, AST and GGT activity. In chronic hepatitis C virus, the entropy indexes of leukocyte formula, RC, Ilimph, AI, ILG and IL ESR were increased. Positive ANAs were significantly more frequently identified than AMAs.
topic chronic hepatitis c virus
genotype
activity
clinical and biochemical blood test
integrative parameters
url http://zmj.zsmu.edu.ua/article/view/208363/211686
work_keys_str_mv AT ahlishnevska changesinclinicalbiochemicalimmunologicalandintegrativeparametersinpatientswithchronichepatitiscvirusinfectionaccordingtothevirusgenotypeandthegradeofactivity
AT mdchemych changesinclinicalbiochemicalimmunologicalandintegrativeparametersinpatientswithchronichepatitiscvirusinfectionaccordingtothevirusgenotypeandthegradeofactivity
_version_ 1724623286122315776
spelling doaj-cb07784f5eeb47bc8c24742f86d388002020-11-25T03:19:18ZengZaporozhye State Medical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102020-08-0122448549410.14739/2310-1210.2020.4.208363Changes in clinical, biochemical, immunological and integrative parameters in patients with chronic hepatitis C virus infection according to the virus genotype and the grade of activityA. H. Lishnevska 0M. D. Chemych1Sumy State University, UkraineSumy State University, UkraineThe aim of this study is to determine the features of the course of chronic hepatitis C virus (CHCV) infection and the dependence of changes in integrative indicators of endogenous intoxication, nonspecific immunoreactivity and inflammation on the virus genotype and the grade of activity. Materials and methods. In total, 287 CHCV patients were examined and their inpatient and outpatient medical cards were analyzed. The study included 55 healthy individuals. In addition to the general group, which included all the patients, the examined people were divided into groups, depending on the grade of activity (minimal activity – 210 people, moderate – 68, expressed – 9) and the virus genotype (1b – 150 people, 2 – 19, 3a – 102). Clinical and laboratory examination was performed according to the protocol. The integrative indices of severity, nonspecific reactivity, indices of inflammation and intoxication activity were also calculated. The statistical processing of the obtained results was carried out by Microsoft Office Excel 2010 and IBM SPSS Statistic 23 computer software. Results. The groups were sex- and age-representative. The 1b genotype (52.30 %), moderate liver fibrosis (F2 – 31.25 %) and minimal activity (73.17 %) were the most frequently encountered in patients with CHCV. The most frequent clinical manifestations were asthenovegetative syndrome (81.88 %) and heaviness in the right hypochondrium (64.76 %). Patients with CHCV caused by different virus genotypes had evenly distributed clinical data (P > 0.05), with the exception of the 1b genotype patients who were diagnosed with telangiectasia 1.3 times more frequently than in the total sample; and liver enlargement were 1.5 times (P < 0.05) less frequently seen in the 2 genotype patients, there were no anemia cases (P < 0.05). A decrease in platelet counts (1.3 times) and segmented neutrophils (1.2 times) as well as an increase in lymphocytes (1.1 times) and ESR (1.4 times) was observed in CHCV patients compared to apparently healthy individuals (P < 0.05). The changes obtained were significant in the groups with all genotypes, except for the patients with genotype 2 as the level of erythrocytes and hemoglobin was lower than in the comparison group and in the total group (1.1 times in all cases, P < 0.05), and patients with genotype 3 had a lower ESR compared to all patients (1.2 times) (P < 0.05). The groups of patients with different grades of activity were homogeneous with the exception that the leukocyte count in minimal activity (P < 0.05) was lower than in the total group, ESR was higher only in the total group in minimal activity (P < 0.05), the level of segmented neutrophils and lymphocytes in expressed activity did not differ from the comparison group, unlike other groups. In the total group, leukopenia (15.68 %), erythrocytopenia (18.47 %), anemia (6.62 %), and thrombocytopenia (33.10 %) were more common than in the comparison group (5.45 %, 3.63%, 0 %, 5.45 %, respectively) (P < 0.05). People with different HCV genotypes had similar changes, except for the patients with genotype 2 who did not have anemia. All CHCV patients had higher values of total protein, ALT, AST, GGT relative to the comparison group (P < 0.05), and AlP and creatinine were lower (P < 0.05). No dependence of changes in these parameters on the genotype was found, except for protein content, as it was higher in the groups with genotype 1c and 2; AlP was lower in individuals with the 1c and 3a, and creatinine – in 1c and 2 genotype patients (P < 0.05). There was also no dependence of changes in patients with CHCV on the grade of activity, except for those with expressed activity who had higher AlP, GGT and total bilirubin with reduced glucose level (P < 0.05). In the total group of patients with CHCV, the entropy indices of leukocyte formula were higher, the indexes of nonspecific reactivity had higher values of RC (1.3 times), Ilimph (1.3 times), IA (1.1 times), but NMRI (1.1 times) and ELRI (1.3) (P < 0.05) were lower than in the comparison group. There was a decrease (TII – 1.1 times; KI– 1.3 times) or an increase (ILG – 1.3 times; IL ESR – 1.5 times) in inflammatory parameters (P < 0.05). Indices of endogenous intoxication were decreased in patients compared with the healthy individuals (ILS – 1.2 times, NRR – 1.8 times). No dependence of changes in patients with CHCV on the genotype was found, except for IA, which was higher only in the total group and with genotype 3a (P < 0.05), and IL ESR in the patients with genotype 3a, which was lower than in the total group (P < 0.05) but did not differ from the comparison group (p> 0.05); IIS with genotype 3a was 1.7 times lower compared with all patients (P < 0.05). The ELR indicator did not change in all grades of activity and did not differ from those of healthy individuals. In patients with moderate activity, IA was higher than in the comparison group and NI was lower than in the total group (P < 0.05). Abdominal ultrasound, regardless of the group, most frequently revealed liver enlargement (76.26% of persons) and an increase in its echogenicity (82.35 %). Conclusions. Chronic hepatitis C virus patients were dominated by asthenovegetative syndrome, feeling of heaviness in the right hypochondrium, liver enlargement, increase in lymphocyte count, ESR, transaminase activity. Telangiectasia in genotype 1b and liver enlargement in genotype 2 were less frequent. Laboratory changes were accompanied by leukocytopenia, erythrocytopenia, anemia and thrombocytopenia, an increase in total protein content, ALT, AST and GGT activity. In chronic hepatitis C virus, the entropy indexes of leukocyte formula, RC, Ilimph, AI, ILG and IL ESR were increased. Positive ANAs were significantly more frequently identified than AMAs. http://zmj.zsmu.edu.ua/article/view/208363/211686chronic hepatitis c virusgenotypeactivityclinical and biochemical blood testintegrative parameters